Let CRISPR/Cas9 battle commence
The CRISPR patent war
vitstudio / Shutterstock.com
Scientists from two US universities will fight out the ownership of the intellectual property rights to the CRISPR/Cas9 technology after the US Patent and Trademark Office (USPTO) agreed to initiate an interference proceeding.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
CRISPR/Cas 9; USPTO; Deborah Katz; Massachusetts Institute of Technology; University of California; gene-editing; DNA